Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Emergency Filtration Products (EFP) was a medical device company that developed and marketed specialized air filtration products for the healthcare and consumer markets. The company's core innovation was the 2H Technology, a patented dual-filter system designed to capture and neutralize airborne pathogens, including viruses and bacteria. Their product portfolio included the NanoMask and the 2H Respirator, which were marketed as high-efficiency alternatives to standard N95 masks during outbreaks such as SARS and avian flu. EFP's technology utilized nanotechnology to enhance the filtration of sub-micron particles, providing a higher level of protection for healthcare workers and first responders. Despite initial commercial success and public interest during global health emergencies in the mid-2000s, the company eventually ceased active operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Emergency Filtration Products.